Facephi Biometria, S.A. (BME: FACE)

Facephi Biometria Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	4.98	4.98	4.79	3.86	1.61	0.69
Short-Term Investments	18.64	18.64	14.71	12.28	8.05	11.32
Cash & Short-Term Investments	23.62	23.62	19.5	16.13	9.67	12.01
Cash Growth	21.12%	21.12%	20.89%	66.92%	-19.52%	113.35%
Accounts Receivable	19.85	19.85	23.46	15.81	15.97	15.76
Other Receivables	0.18	0.18	0.37	0.09	0.07	0.04
Receivables	20.03	20.03	23.83	15.9	16.03	15.8
Inventory	0.46	0.46	0.57	0.85	0.68	0.88
Other Current Assets	-	-	0	-	-	-
Total Current Assets	44.12	44.12	43.9	32.89	26.38	28.69
Property, Plant & Equipment	15.72	15.72	15.91	10.89	13.37	14.01
Long-Term Investments	7.27	7.27	10.5	10.02	13.66	7.42
Goodwill	5.96	5.96	6.06	8.03	10.04	12.04
Other Intangible Assets	0.03	0.03	0.04	0.1	0.22	0.33
Long-Term Deferred Tax Assets	1.99	1.99	2.14	1.45	1.22	0.95
Long-Term Deferred Charges	0.04	0.04	0.04	-	-	-
Other Long-Term Assets	-	-	-	-	-	0
Total Assets	75.12	75.12	78.59	63.38	64.88	63.44
Accounts Payable	13.47	13.47	19.31	12.95	12.77	16.17
Accrued Expenses	-	-	-	1.01	3.69	2.53
Current Portion of Long-Term Debt	8.42	8.42	6.7	7.17	7.61	3.5
Current Portion of Leases	0.72	0.72	0.76	0.77	0.75	0.52
Current Income Taxes Payable	0	0	0	-	-	-
Other Current Liabilities	5.8	5.8	4.93	1.88	1.76	1.46
Total Current Liabilities	28.41	28.41	31.7	23.78	26.57	24.17
Long-Term Debt	7.29	7.29	10.55	5.92	1.54	5.07
Long-Term Leases	0.73	0.73	1.32	2.09	2.85	2.12
Long-Term Deferred Tax Liabilities	0.43	0.43	0.31	0.4	0.54	0.61
Other Long-Term Liabilities	0.12	0.12	0.3	0.38	4.42	3.8
Total Liabilities	36.98	36.98	44.19	32.57	35.91	35.77
Common Stock	0.61	0.61	0.61	0.61	0.61	0.61
Additional Paid-In Capital	26.61	26.61	26.61	26.61	26.61	26.61
Retained Earnings	3.68	3.68	3.91	2.07	1.47	0.29
Treasury Stock	-0.47	-0.47	-0.47	-0.48	-0.49	-0.62
Comprensive Income & Other	7.7	7.7	3.72	1.97	0.75	0.76
Total Common Equity	38.13	38.13	34.37	30.79	28.94	27.65
Minority Interest	0.02	0.02	0.02	0.02	0.02	0.02
Shareholders' Equity	38.15	38.15	34.39	30.81	28.96	27.67
Total Liabilities & Equity	75.12	75.12	78.59	63.38	64.88	63.44
Total Debt	17.16	17.16	19.35	15.95	12.75	11.2
Net Cash (Debt)	6.46	6.46	0.16	0.19	-3.08	0.81
Net Cash Growth	3991.79%	3991.79%	-15.60%	-	-	-
Net Cash Per Share	0.21	0.21	0.01	0.01	-0.10	0.03
Filing Date Shares Outstanding	30.38	30.38	30.39	30.39	30.37	30.34
Total Common Shares Outstanding	30.38	30.38	30.39	30.39	30.37	30.34
Working Capital	15.71	15.71	12.2	9.11	-0.19	4.52
Book Value Per Share	1.25	1.25	1.13	1.01	0.95	0.91
Tangible Book Value	32.14	32.14	28.27	22.66	18.69	15.27
Tangible Book Value Per Share	1.06	1.06	0.93	0.75	0.62	0.50
Land	1.35	1.35	0.91	0.25	0.25	0.25
Buildings	5.24	5.24	5.17	2.1	2.07	1.99
Construction In Progress	2.13	2.13	1.38	1.47	0.95	0.01

Source: S&P Capital IQ. Standard template. Financial Sources.